Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
-
- STATUS
- Recruiting
-
- End date
- Apr 30, 2024
-
- participants needed
- 1140
-
- sponsor
- Chinese University of Hong Kong
Summary
To determine if the use of Buscopan in patients undergoing IVF/ICSI treatment with high uterine contraction frequency prior to embryo transfer has a higher live birth rate.
Details
| Condition | assisted reproductive technology, Intracytoplasmic sperm injection, In Vitro Fertilization, In Vitro Fertilization, assisted reproductive technologies, icsi |
|---|---|
| Treatment | Buscopan 20 milligrams/ML Injectable Solution |
| Clinical Study Identifier | NCT04751084 |
| Sponsor | Chinese University of Hong Kong |
| Last Modified on | 17 February 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer